i-SENS, Inc. Develops ‘Glucometer’ with Cutting-Edge Biosensor Technology

News provided by

i-SENS, Inc. KOSDAQ 099190

Oct. 26, 2011 15:49

공유
스크랩
인쇄
글자크기
Font Size
- ASmall
- AMedium
- ALarge
- AVery Large

SEOUL--(Korea Newswire)--Glucose monitor-specialized company i-SENS Inc. has developed and is distributing diagnostic devices such as glucose monitors based on cutting-edge biosensor technology and electrochemical technology.

Since the foundation on May 2000, i-SENS’ first glucose monitor system has entered, let alone Korea, into markets of advanced nations such as U.S, Japan, and Europe, with the recognition of outstanding technological power.

Developed with independent technology, glucose monitoring system ‘CareSens’can accurately measure blood glucose level within 5 seconds with just a minimal amount of blood of less than 0.5㎕. As it can take measurements with a minimal amount of blood (0.5㎕), it is easily used by children or the elderly, and it can be used at body parts that could not be used for measurement due to the amount of blood taken being too small such as palm, forearm, or thigh without pain.

i-SENS Inc. will take this year as the year of inauguration of the next 10 successful years, and plans to prepare for an even stronger competitiveness in the fierce market by securing production cost competitiveness through automation process, defect rate/yield improvement, and suppression of unnecessary costs as there are many factors pressing the production cost increase such as high oil prices and increased price of raw materials.

Geun-Sig Cha, CEO of i-SENS, Inc. said that “based on the technological development experience, patents, and research capability accumulated throughout the years, we will continue to develop and release innovative and easy-to-use products” and that “the mindset at the early times of foundation, ‘based on the cutting-edge technology, the diagnostic products will be developed and sold to contribute to the health of the mankind’ will be meditated on, and through endless research and investment in core technology, we shall grow to be a global company by supplying the world’s best products to the market.”

In the meantime, i-SENS Inc. is constructing the 2nd blood glucose strip plant in Songdo based on the platform of Wonju factory., . Songdo is expected to be another niche for company-growth, and perfection is in the floor plan for the completion of the plant which will be anther foundation for growth in sales. (Inquiries: +82-2-910-0687, jlee@i-sens.com)

Website: http://i-sens.com